Molecular Profiles of Cell-to-Cell Variation in the Regenerative Potential of Mesenchymal Stromal Cells
- PMID: 31636675
- PMCID: PMC6766122
- DOI: 10.1155/2019/5924878
Molecular Profiles of Cell-to-Cell Variation in the Regenerative Potential of Mesenchymal Stromal Cells
Abstract
Cell-to-cell variation in the regenerative potential of mesenchymal stromal cells (MSCs) impedes the translation of MSC therapies into clinical practice. Cellular heterogeneity is ubiquitous across MSC cultures from different species and tissues. This review highlights advances to elucidate molecular profiles that identify cell subsets with specific regenerative properties in heterogeneous MSC cultures. Cell surface markers and global signatures are presented for proliferation and differentiation potential, as well as immunomodulation and trophic properties. Key knowledge gaps are discussed as potential areas of future research. Molecular profiles of MSC heterogeneity have the potential to enable unprecedented control over the regenerative potential of MSC therapies through the discovery of new molecular targets and as quality attributes to develop robust and reproducible biomanufacturing processes. These advances would have a positive impact on the nascent field of MSC therapeutics by accelerating the development of therapies with more consistent and effective treatment outcomes.
Copyright © 2019 Kim C. O'Connor.
Conflict of interest statement
The author is an inventor listed on patents and patent applications entitled “Method for Identification and Culture of Multipotent Mesenchymal Stem Cells with High Proliferation Potential” issued in Austria, China, and Germany; pending issuance in France, Switzerland, and UK; and under review in Canada, India, Japan, and the US. In addition, the author is the inventor listed on a patent application entitled “Cell-Surface Marker of Early MSC Aging” pending issuance in the US and under review in Australia, Canada, and Europe.
Figures

Similar articles
-
Strategies to address mesenchymal stem/stromal cell heterogeneity in immunomodulatory profiles to improve cell-based therapies.Acta Biomater. 2021 Oct 1;133:114-125. doi: 10.1016/j.actbio.2021.03.069. Epub 2021 Apr 20. Acta Biomater. 2021. PMID: 33857693 Review.
-
Glucose Metabolism: Optimizing Regenerative Functionalities of Mesenchymal Stromal Cells Postimplantation.Tissue Eng Part B Rev. 2023 Feb;29(1):47-61. doi: 10.1089/ten.TEB.2022.0063. Epub 2023 Jan 25. Tissue Eng Part B Rev. 2023. PMID: 35754335 Review.
-
Decoy TRAIL receptor CD264: a cell surface marker of cellular aging for human bone marrow-derived mesenchymal stem cells.Stem Cell Res Ther. 2017 Sep 29;8(1):201. doi: 10.1186/s13287-017-0649-4. Stem Cell Res Ther. 2017. PMID: 28962588 Free PMC article.
-
Recent Trends in Multipotent Human Mesenchymal Stem/Stromal Cells: Learning from History and Advancing Clinical Applications.OMICS. 2021 Jun;25(6):342-357. doi: 10.1089/omi.2021.0049. Epub 2021 May 25. OMICS. 2021. PMID: 34115524 Review.
-
Metabolomics and cytokine profiling of mesenchymal stromal cells identify markers predictive of T-cell suppression.Cytotherapy. 2022 Feb;24(2):137-148. doi: 10.1016/j.jcyt.2021.08.002. Epub 2021 Oct 22. Cytotherapy. 2022. PMID: 34696960
Cited by
-
Intrinsic Type 1 Interferon (IFN1) Profile of Uncultured Human Bone Marrow CD45lowCD271+ Multipotential Stromal Cells (BM-MSCs): The Impact of Donor Age, Culture Expansion and IFNα and IFNβ Stimulation.Biomedicines. 2020 Jul 15;8(7):214. doi: 10.3390/biomedicines8070214. Biomedicines. 2020. PMID: 32679782 Free PMC article.
-
Dental Pulp Stem Cell Heterogeneity: Finding Superior Quality "Needles" in a Dental Pulpal "Haystack" for Regenerative Medicine-Based Applications.Stem Cells Int. 2022 Jan 4;2022:9127074. doi: 10.1155/2022/9127074. eCollection 2022. Stem Cells Int. 2022. PMID: 35027930 Free PMC article. Review.
-
Stem Cells Derived from Human Exfoliated Deciduous Teeth Functional Assessment: Exploring the Changes of Free Fatty Acids Composition during Cultivation.Int J Mol Sci. 2023 Dec 8;24(24):17249. doi: 10.3390/ijms242417249. Int J Mol Sci. 2023. PMID: 38139076 Free PMC article.
-
CD271+ stem cell treatment of patients with chronic stroke: : A retrospective case series report.Exp Ther Med. 2020 Sep;20(3):2055-2062. doi: 10.3892/etm.2020.8948. Epub 2020 Jun 26. Exp Ther Med. 2020. PMID: 32782517 Free PMC article.
-
Influence of age on stem cells depends on the sex of the bone marrow donor.J Cell Mol Med. 2022 Mar;26(5):1594-1605. doi: 10.1111/jcmm.17201. Epub 2022 Jan 27. J Cell Mol Med. 2022. PMID: 35088539 Free PMC article.
References
-
- Friedenstein A. J., Chailakhyan R. K., Latsinik N. V., Panasyuk A. F., Keiliss-Borok I. V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues: Cloning in vitro and retransplantation in vivo. Transplantation. 1974;17(4):331–340. doi: 10.1097/00007890-197404000-00001. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources